561287c0-figure-01 (Buprenorphine And Naloxone Sublingual Tablets 1)
Buprenorphine Hcl And Naloxone Hcl Tablet
Product Images NDC 65162-415
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl And Naloxone Hcl (NDC 65162-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
561287c0-figure-02 (Buprenorphine And Naloxone Sublingual Tablets 2)
1 (Buprenorphine And Naloxone Sublingual Tablets 3)
2mg Label (Buprenorphine And Naloxone Sublingual Tablets 4)
NDC 65162-416-09 is a prescription drug containing 90 sublingual tablets of Buprenorphine and Naloxone. It is usually used for treating opioid dependence. The medication guide should be provided separately by the pharmacist while dispensing. The tablets should be stored in a controlled room temperature between 20°C to 25°C, and excursions permitted between 15°C to 30°C. In case of accidental intake by children, immediate medical help is required. The drug is manufactured by Amneal Pharmaceuticals of NY LLC and distributed by Amneal Pharmaceuticals LLC based in Glasgow, KY. The available lot number and expiry date are provided in a non-varnish area of the package.*
8 mg Label (Buprenorphine And Naloxone Sublingual Tablets 5)
This is a description of the drug Buprenorphine Naloxone, which is available in sublingual tablets. The recommended dosage can be found in the package insert, which also contains prescribing information. The drug should be stored at a temperature between 20° to 25°C (68" to 77°F). The tablets may be kept between 15° to 30°C (59° to 86°F) according to the USP controlled room temperature regulations. The NDC number of the tablet is 65162-415-09. The drug should be kept out of the reach of children. The manufacturer of the drug is Amneal Pharmaceuticals of NY LLC, and it is distributed by Amneal Pharmaceuticals LLC of Glasgow, KY 42141. The description also includes a lot number and revision date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
